Intravitreal drug delivery has become the gold standard for treatment of many retinal diseases, including neovascular age-related macular degeneration (AMD), diabetic retinopathy, and retinal vein occlusion.

An intravitreal (pronounced in tra VIT re al) injection is a procedure to place a medication directly into the space in the back of the eye called the vitreous cavity, which is filled with a jelly-like fluid called the vitreous humor gel. The procedure is usually performed by a trained retina specialist in the office setting.

Intravitreal injection is used to inject a drug into the eye to reduce inflammation (anti-inflammatory), inhibit the growth and development of new blood vessels (angiostatic), or lower the permeability of blood vessels (anti-permeability), in turn curing various eye diseases.

2013年4月1日 · Intravitreal injection enables highly targeted drug therapy, maximizing therapeutic drug delivery to the posterior pole while minimizing systemic toxicity.

2015年1月6日 · Treatment of retinal disease by intravitreal injection (IVI) has revolutionized the field of ophthalmology. It is estimated that over four million IVIs were performed in the United States in 2013, a number that is expected to continue to increase [1].

Intravitreal (IVT) injection of therapeutic agents has become one of the most commonly performed procedures in ophthalmology. Over the past decade, a number of guidelines have been published that recommend proper techniques to increase the safety of IVT injections.

2022年11月10日 · An intravitreal injection is a shot of medicine into the eye. The inside of the eye is filled with a jelly-like fluid (vitreous). During this procedure, your health care provider (usually an ophthalmologist) injects medicine into the vitreous, near the retina at the back of the eye.

Patients with these retinal conditions can lose central vision when abnormal blood vessels bleed or leak fluid under the retina at the back of the eye. A series of injections of anti-VEGF medicines are given into the back of the eye to stop these blood vessels growing and …

The aim of this guidance is to provide advice about performing all intravitreal injection therapy (IVT) as safely as possible, whilst supporting the requirement for innovative and efficient models of care to deal with the continuing increase in demand.

药物直接注入眼内可以有效地治疗一系列视网膜疾病。 使用的药物包括Lucentis（雷珠单抗），Eylea (阿柏西普)，Avastin（贝伐单抗）和Ozurdex（地塞米松）。 所有药物已被证明对防止视力丧失有效。 你的眼科医生会和你讨论选择最好的药物。 药物的选择取决于治疗的情况、全身健康状况和个体对药物的反应。 如果你有玻璃体腔注射治疗的疑问，向我们的眼科医生 预约，让她提供你专业建议，并接受适当的治疗。 治疗前该如何准备？ 注射时痛吗？ 注射后我要做什 …